ReNeuron gets approval to start a Phase I/II clinical trial in the US in retinitis pigmentosa
5 May 2015 | By Victoria White
ReNeuron has received approval from the FDA to commence a Phase I/II clinical trial in the US with its hRPC therapy candidate for retinitis pigmentosa...